Finance

Lists
1SXP:ETR
SCHOTT Pharma AG & Co KgaA
22,60 €
+0,67%
(+0,15) 1D
18 նոյ, 17:35:02 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1SXP...
Open
22,20 €
High
22,95 €
Low
22,20 €
Mkt. cap
3,40 մլրդ
Avg. vol.
86,68 հզր
Volume
46,00 հզր
Dividend
0,80%
Quarterly dividend
0,05 €
Ex-dividend date
2026 թ. փտվ 4
P/E ratio
24,77
52-wk high
26,20 €
52-wk low
12,62 €
EPS
0,91 €
Shares outstanding
150,61 մլն
No. of employees
5 հզր
Open
22,20 €
High
22,95 €
Low
22,20 €
Mkt. cap
3,40 մլրդ
Avg. vol.
86,68 հզր
Volume
46,00 հզր
Dividend
0,80%
Quarterly dividend
0,05 €
Ex-dividend date
2026 թ. փտվ 4
P/E ratio
24,77
52-wk high
26,20 €
52-wk low
12,62 €
EPS
0,91 €
Shares outstanding
150,61 մլն
No. of employees
5 հզր
News stories
From web sources and news partners
Profile
Schott Pharma is a provider of drug containment solutions and delivery systems for injectable drugs. Originally a division of glass manufacturer Schott AG, the company went public on the Frankfurt Stock Exchange in 2023. Headquartered in Mainz, Germany, the company operates in 14 countries. Wikipedia
About SCHOTT Pharma AG & Co KgaA
CEO-
Employees5 հզր
Founded2022 թ. օգս 1
Headquarters-
SectorHealth Care
Industry-
Last report
2026 թ. օգս 12
Fiscal period
Q3 2026
0,26 € / 0,26 €
-1,81%miss
Revenue / Est. (EUR)
281,76 մլն / 272,46 մլն
+3,41%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
247,58 մլն
240,19 մլն
247,88 մլն
281,76 մլն
Cost of goods sold
171,50 մլն
160,44 մլն
172,78 մլն
195,38 մլն
Cost of revenue
171,50 մլն
160,44 մլն
172,78 մլն
195,38 մլն
Research and development expenses
6,36 մլն
7,34 մլն
6,05 մլն
6,34 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
32,89 մլն
33,73 մլն
32,51 մլն
35,30 մլն
Operating expense
35,95 մլն
40,70 մլն
35,55 մլն
37,48 մլն
Total operating expenses
207,45 մլն
201,14 մլն
208,33 մլն
232,86 մլն
Operating income
40,14 մլն
39,05 մլն
39,55 մլն
48,90 մլն
Other non operating income
-61,00 հզր
-79,00 հզր
-212,00 հզր
-116,00 հզր
EBT including unusual items
41,76 մլն
42,04 մլն
40,31 մլն
51,23 մլն
EBT excluding unusual items
41,02 մլն
42,04 մլն
40,31 մլն
51,23 մլն
Income tax expense
8,09 մլն
8,76 մլն
9,17 մլն
12,25 մլն
Effective tax rate
19,37%
20,84%
22,76%
23,91%
Other operating expenses
-3,30 մլն
-366,00 հզր
-3,01 մլն
-4,16 մլն
Net income
33,56 մլն
33,18 մլն
31,01 մլն
38,83 մլն
Net profit margin
13,55%
13,81%
12,51%
13,78%
Earnings per share
0,22
0,22
0,21
0,26
Interest and investment income
2,02 մլն
2,33 մլն
1,84 մլն
1,96 մլն
Interest expense
-4,71 մլն
-4,00 մլն
-4,01 մլն
-3,87 մլն
Net interest expenses
-2,69 մլն
-1,67 մլն
-2,16 մլն
-1,91 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
56,70 մլն
60,46 մլն
61,41 մլն
71,14 մլն
Gain or loss from assets sale
-88,00 հզր
-48,00 հզր
-72,00 հզր
48,00 հզր
Upcoming events
AI content may include mistakes. Learn more
Google Apps